Furosemide tablets

Original title (Estonian): Furosemide Tablets

DLA Troop Support · United States government procurement

Closed March 12, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Furosemide Tablets. Procurement details follow.

Furosemide Tablets: 20 MG and 40 MG in 90 and 1,000 count bottles and 80 MG in 500 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  

A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Nancy Fernandez at (445) 737-0713 or Nancy.Fernandez@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is April of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyDLA Troop Support
CountryUnited States
CategoryPharmaceuticals
NAICS325412
PSC6505
PublishedMarch 12, 2026
Procurement stageActive solicitation
ClosedMarch 12, 2026
StatusClosed — no longer accepting responses
TranslationTranslated from Estonian by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedAugust 27, 2026

Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Browse Similar Open Opportunities in United States

PPVG GEN V Award
National Retardant
PPVG GEN V AWARD SPE2DX25D8000
Febuxostat National Contract
Ziprasidone Capsules
Hydrocodone Acetaminophen
Olanzapine SPE2D2-25-D-0011 Award
Olopatadine HCL 0.1% Ophthalmic Solution

See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Pharmaceuticals intelligence report in your inbox

A personalized report on United States Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.